Horatio F. Wildman

Imatinib mesylate (Gleevec) in the treatment of diffuse cutaneous systemic sclerosis: results of a 1-year, phase IIa, single-arm, open-label clinical trial

Robert Spiera, Jessica Gordon, Jamie Mersten et al. · Annals of the Rheumatic Diseases · 2011 · 174 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +13

Belimumab for the Treatment of Early Diffuse Systemic Sclerosis

Jessica Gordon, Viktor Martyanov, Jennifer M. Franks et al. · Arthritis & Rheumatology · 2017 · 132 citations · Full text

Medicine, Clinical Sciences, Pharmacology +13

Nilotinib (Tasigna™) in the treatment of early diffuse systemic sclerosis: an open-label, pilot clinical trial

Jessica Gordon, Viktor Martyanov, Cynthia M. Magro et al. · Arthritis Research & Therapy · 2015 · 94 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +5

Imatinib mesylate (Gleevec) in the treatment of diffuse cutaneous systemic sclerosis: results of a 24-month open label, extension phase, single-centre trial.

Jessica Gordon, Uzunma Udeh, Kamini Doobay et al. · PubMed · 2015 · 33 citations

Medicine, Clinical Sciences, Pharmacotherapy +9

Effects of leptin and cholecystokinin in rats with a null mutation of the leptin receptor<i>Lepr</i> ^<i>fak</i>

Horatio F. Wildman, Streamson C. Chua, Rudolph L. Leibel et al. · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · 2000 · 16 citations

Life Sciences, Endocrinology, Physiology +17